跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUNITINIB VIVANTA 37,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUNITINIB VIVANTA 37,5 MG CAPSULAS DURAS EFG
Approved
STANDARD
SUNITINIB VIVANTA 37,5 MG CAPSULAS DURAS EFG
Vivanta Generics S.R.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 21, 2022
Approval ID
56f0474fff0b7272
Company
Vivanta Generics S.R.O.
Type
Standard
Approval Details
Approval Id
56f0474fff0b7272
Drug Cima Aemps Name
SUNITINIB VIVANTA 37,5 MG CAPSULAS DURAS EFG
Register Number
86911
Holder Company Name
Vivanta Generics S.R.O.
Marketing Company Name
Vivanta Generics S.R.O. Sucursal En Espana
Authorization Date
2022-04-21
Dosage Form
CÁPSULA DURA
Dose
37,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Vivanta Generics S.R.O.
Active Ingredients
SUNITINIB MALATO
50,12 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 21, 2022
Approval ID
56f0474fff0b7272
Type
Standard
Back to CIMA-AEMPS Approvals
